Bardoxolone methyl
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Biogen
Overview
Bardoxolone methyl is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Bardoxolone methyl clinical trials
Explore related
Medical disclaimer. This page summarizes research about Bardoxolone methyl for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.